Cat.#: ACPP-1846
| Despition | FGF 9 Human Recombinant |
| SIZE | 5 µg |
| Purity | > 95.0% by RP-HPLC and SDS-PAGE. |
| Form | Sterile Filtered white lyophilized powder. |
| Storage | Lyophilized was stored and desiccated below -18°C. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1627 | Human Visfatin Protein, His (AC1627) | 5 µg | inquiry |
| ACPP-1776 | Human Acrp30 Protein, HMW (AC1776) | 2 µg | inquiry |
| ACPP-1046 | Recombinant Mouse CD45 Protein (6×His Tag) (AC1046) | 50 µg | inquiry |
| ACPP-1147 | Recombinant Human NRP2 Protein (6×His Tag) (AC1147) | 50 µg | inquiry |
| ACPP-1135 | ACTH Blocking Peptide (AC1135) | 250 µg | inquiry |
| ACPP-1555 | Human TGFBI Protein, 182 a.a. (AC1555) | 10 µg | inquiry |
| ACPP-1626 | Human SHC1 Protein (AC1626) | 5 µg | inquiry |
| ACPP-1095 | Synthetic Nanodisc Human MLC1 Protein (AC1095) | 10 µg | inquiry |
| ACPP-1762 | Human SNAP25 Protein, His (AC1762) | 10 µg | inquiry |
| ACPP-1086 | Synthetic Nanodisc Human Somatostatin Receptor 2 Protein (AC1086) | 10 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.